In silico model of the human ClC-Kb chloride channel: pore mapping, biostructural pathology and drug screening

Abstract : The human ClC-Kb channel plays a key role in exporting chloride ions from the cytosol and is known to be involved in Bartter syndrome type 3 when its permeation capacity is decreased. The ClC-Kb channel has been recently proposed as a potential therapeutic target to treat hypertension. In order to gain new insights into the sequence-structure-function relationships of this channel, to investigate possible impacts of amino-acid substitutions, and to design novel inhibitors, we first built a structural model of the human ClC-Kb channel using comparative modeling strategies. We combined in silico and in vitro techniques to analyze amino acids involved in the chloride ion pathway as well as to rationalize the possible role of several clinically observed mutations leading to the Bartter syndrome type 3. Virtual screening and drug repositioning computations were then carried out. We identified six novel molecules, including 2 approved drugs, diflusinal and loperamide, with Kd values in the low micromolar range, that block the human ClC-Kb channel and that could be used as starting point to design novel chemical probes for this potential therapeutic target.
Type de document :
Article dans une revue
Scientific Reports, Nature Publishing Group, 2017, 7, pp.7249. 〈10.1038/s41598-017-07794-5〉
Liste complète des métadonnées

Littérature citée [95 références]  Voir  Masquer  Télécharger

http://hal.upmc.fr/hal-01580157
Contributeur : Gestionnaire Hal-Upmc <>
Soumis le : vendredi 1 septembre 2017 - 10:30:10
Dernière modification le : mercredi 7 février 2018 - 08:36:02

Fichier

s41598-017-07794-5.pdf
Publication financée par une institution

Licence


Distributed under a Creative Commons Paternité 4.0 International License

Identifiants

Citation

Maxime Louet, Sara Bitam, Naziha Bakouh, Yohan Bignon, Gabrielle Planelles, et al.. In silico model of the human ClC-Kb chloride channel: pore mapping, biostructural pathology and drug screening. Scientific Reports, Nature Publishing Group, 2017, 7, pp.7249. 〈10.1038/s41598-017-07794-5〉. 〈hal-01580157〉

Partager

Métriques

Consultations de la notice

88

Téléchargements de fichiers

40